Cambiar Investors LLC lowered its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 16.4% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 20,515 shares of the company's stock after selling 4,035 shares during the quarter. Cambiar Investors LLC owned 0.14% of U.S. Physical Therapy worth $1,484,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the company. Portside Wealth Group LLC raised its stake in shares of U.S. Physical Therapy by 3.9% during the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after purchasing an additional 154 shares in the last quarter. Precision Wealth Strategies LLC raised its stake in shares of U.S. Physical Therapy by 6.6% during the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after purchasing an additional 189 shares in the last quarter. Aquatic Capital Management LLC raised its stake in shares of U.S. Physical Therapy by 18.0% during the 4th quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company's stock worth $115,000 after purchasing an additional 198 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of U.S. Physical Therapy by 4.4% during the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after purchasing an additional 208 shares in the last quarter. Finally, Albert D Mason Inc. raised its stake in shares of U.S. Physical Therapy by 2.5% during the 1st quarter. Albert D Mason Inc. now owns 10,856 shares of the company's stock worth $786,000 after purchasing an additional 260 shares in the last quarter.
U.S. Physical Therapy Stock Performance
Shares of USPH stock traded up $3.0470 during trading on Friday, reaching $87.5170. 138,967 shares of the company's stock were exchanged, compared to its average volume of 192,953. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $1.33 billion, a PE ratio of 38.22, a PEG ratio of 4.32 and a beta of 1.45. U.S. Physical Therapy, Inc. has a twelve month low of $62.77 and a twelve month high of $101.19. The firm's fifty day moving average price is $78.26 and its 200-day moving average price is $76.91.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.71 by $0.10. The business had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The firm's quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.73 EPS. As a group, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.
U.S. Physical Therapy Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 12th. Investors of record on Friday, August 22nd will be paid a $0.45 dividend. The ex-dividend date is Friday, August 22nd. This represents a $1.80 annualized dividend and a yield of 2.1%. U.S. Physical Therapy's payout ratio is 78.60%.
Insider Buying and Selling at U.S. Physical Therapy
In other news, Director Nancy Ham sold 400 shares of the company's stock in a transaction on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, COO Graham D. Reeve sold 763 shares of the company's stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $84.97, for a total value of $64,832.11. Following the sale, the chief operating officer owned 21,483 shares of the company's stock, valued at approximately $1,825,410.51. The trade was a 3.43% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 2,955 shares of company stock valued at $251,170 over the last 90 days. 2.00% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
USPH has been the topic of a number of analyst reports. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Zacks Research upgraded U.S. Physical Therapy to a "hold" rating in a research note on Friday, August 8th. Finally, Barrington Research upped their price objective on U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $110.25.
Get Our Latest Stock Report on USPH
U.S. Physical Therapy Profile
(
Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Further Reading

Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.